Amdocs earnings beat by $0.02, revenue was in line with estimates By Investing.com

Investing.com – Amdocs (NASDAQ: ) reported third quarter EPS of $1.62, $0.02 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.25B versus the consensus estimate of $1.25B.

Amdocs’s stock price closed at $81.67. It is down -1.87% in the last 3 months and down -6.99% in the last 12 months.

Amdocs saw 1 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Amdocs’s stock price’s past reactions to earnings here.

According to InvestingPro, Amdocs’s Financial Health score is “good performance”.

Check out Amdocs’s , and Amdocs’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar